Michor Franziska
SEC insider (Form 3/4/5 filer). CIK 0002045159. Director at RECURSION PHARMACEUTICALS, INC. (RXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SALT LAKE CITY, UT.
Companies Michor Franziska has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director
Michor Franziska
CIK: 0002045159
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RECURSION PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect88.4K shares- - Jun 18, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect22K shares- - Nov 20, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect30.6K shares- - Nov 20, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect15.3K shares- - Nov 20, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect17.7K shares- - Nov 20, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect41.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 88,424 | - | $0 | Direct |
| Jun 18, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 22,016 | - | - | Direct |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 30,618 | - | $0 | Direct |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 15,335 | - | $0 | Direct |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 17,694 | - | $0 | Direct |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 41,390 | - | $0 | Direct |
1-6 of 6 transactions